Copyright © 2009 Sergio Comincini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. N. Louis, “Molecular pathology of malignant gliomas,” Annual Review of Pathology, vol. 1, pp. 97–117, 2006. View at Publisher · View at Google Scholar · View at PubMed
2. H. Ohgaki and P. Kleihues, “Genetic pathways to primary and secondary glioblastoma,” American Journal of Pathology, vol. 170, no. 5, pp. 1445–1453, 2007. View at Publisher · View at Google Scholar · View at PubMed
3. S. Higashiyama and D. Nanba, “ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk,” Biochimica et Biophysica Acta, vol. 1751, no. 1, pp. 110–117, 2005. View at Publisher · View at Google Scholar · View at PubMed
4. S. Miyamoto, H. Yagi, F. Yotsumoto, T. Kawarabayashi, and E. Mekada, “Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy,” Cancer Science, vol. 97, no. 5, pp. 341–347, 2006. View at Publisher · View at Google Scholar · View at PubMed
5. S. Hart, O. M. Fischer, and A. Ullrich, “Cannabinoids induce cancer cell proliferation via tumor necrosis factor $\alpha$-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor,” Cancer Research, vol. 64, no. 6, pp. 1943–1950, 2004. View at Publisher · View at Google Scholar
6. C.-H. Kwon, D. Zhao, J. Chen, et al., “Pten haploinsufficiency accelerates formation of high-grade astrocytomas,” Cancer Research, vol. 68, no. 9, pp. 3286–3294, 2008. View at Publisher · View at Google Scholar · View at PubMed
7. Q.-W. Fan, C. K. Cheng, T. P. Nicolaides, et al., “A dual phosphoinositide-3-kinase $\alpha$/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma,” Cancer Research, vol. 67, no. 17, pp. 7960–7965, 2007. View at Publisher · View at Google Scholar · View at PubMed
8. J. B. Johnston, S. Navaratnam, M. W. Pitz, et al., “Targeting the EGFR pathway for cancer therapy,” Current Medicinal Chemistry, vol. 13, no. 29, pp. 3483–3492, 2006. View at Publisher · View at Google Scholar
9. M.-S. Kim, M.-J. Park, E.-J. Moon, S.-J. Kim, C.-H. Lee, and H. Yoo, “Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells,” Cancer Research, vol. 65, no. 3, pp. 686–691, 2005.
10. T. Hastie, R. Tibshirani, D. Botstein, and P. Brown, “Supervised harvesting of expression trees,” Genome Biology, vol. 2, no. 1, article research0003.1-0003.12, 2001. View at Publisher · View at Google Scholar
11. I. K. Mellinghoff, M. Y. Wang, I. Vivanco, et al., “Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors,” The New England Journal of Medicine, vol. 353, no. 19, pp. 2012–2024, 2005. View at Publisher · View at Google Scholar · View at PubMed
12. K. Komatsu, Y. Nakanishi, N. Nemoto, T. Hori, T. Sawada, and M. Kobayashi, “Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas,” Brain Tumor Pathology, vol. 21, no. 3, pp. 105–112, 2004. View at Publisher · View at Google Scholar
13. P. Kleihues and W. K. Cavenee, World Health Organization Classification of Tumors of the Nervous System, Lyon, France, 2000.
14. M. Paolillo, A. Barbieri, P. Zanassi, and S. Schinelli, “Expression of endothelins and their receptors in glioblastoma cell lines,” Journal of Neuro-Oncology, vol. 79, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at PubMed
15. D. N. Louis, E. C. Holland, and J. G. Cairncross, “Glioma classification: a molecular reappraisal,” American Journal of Pathology, vol. 159, no. 3, pp. 779–786, 2001.
16. Y. Liang, M. Diehn, N. Watson, et al., “Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5814–5819, 2005. View at Publisher · View at Google Scholar · View at PubMed
17. F. Wang, R. Liu, S. W. Lee, C. M. Sloss, J. Couget, and J. C. Cusack, “Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance,” Oncogene, vol. 26, no. 14, pp. 2006–2016, 2007. View at Publisher · View at Google Scholar · View at PubMed
18. D. B. Ramnarain, S. Park, D. Y. Lee, et al., “Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells,” Cancer Research, vol. 66, no. 2, pp. 867–874, 2006. View at Publisher · View at Google Scholar · View at PubMed
19. D. S. Rickman, M. P. Bobek, D. E. Misek, et al., “Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis,” Cancer Research, vol. 61, no. 18, pp. 6885–6891, 2001.
20. D. Wildeboer, S. Naus, Q.-X. A. Sang, J. W. Bartsch, and A. Pagenstecher, “Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 5, pp. 516–527, 2006. View at Publisher · View at Google Scholar · View at PubMed
21. C. B. Knobbe, A. Merlo, and G. Reifenberger, “Pten signalling in gliomas,” Neuro-Oncology, vol. 4, no. 3, pp. 196–211, 2002. View at Publisher · View at Google Scholar
22. G. N. Fuller, K. R. Hess, C. H. Rhee, et al., “Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets,” Brain Pathology, vol. 12, no. 1, pp. 108–116, 2002.
23. K. Ichimura, H. Ohgaki, P. Kleihues, and V. P. Collins, “Molecular pathogenesis of astrocytic tumours,” Journal of Neuro-Oncology, vol. 70, no. 2, pp. 137–160, 2004. View at Publisher · View at Google Scholar · View at PubMed
24. B. K. Ahmed Rasheed, R. N. Wiltshire, S. H. Bigner, and D. D. Bigner, “Molecular pathogenesis of malignant gliomas,” Current Opinion in Oncology, vol. 11, no. 3, pp. 162–167, 1999. View at Publisher · View at Google Scholar
25. K. Furukawa, Y. Kumon, H. Harada, et al., “PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules,” International Journal of Oncology, vol. 29, no. 1, pp. 73–81, 2006.
26. M. Raftopoulou, S. Etienne-Manneville, A. Self, S. Nicholls, and A. Hall, “Regulation of cell migration by the C2 domain of the tumor suppressor PTEN,” Science, vol. 303, no. 5661, pp. 1179–1181, 2004. View at Publisher · View at Google Scholar · View at PubMed
27. S. Sathornsumetee, D. A. Reardon, A. Desjardins, J. A. Quinn, J. J. Vredenburgh, and J. N. Rich, “Molecularly targeted therapy for malignant glioma,” Cancer, vol. 110, no. 1, pp. 12–24, 2007. View at Publisher · View at Google Scholar · View at PubMed
28. C. Tricarico, P. Pinzani, S. Bianchi, et al., “Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies,” Analytical Biochemistry, vol. 309, no. 2, pp. 293–300, 2002. View at Publisher · View at Google Scholar
29. S. Waxman and E. Wurmbach, “De-regulation of common housekeeping genes in hepatocellular carcinoma,” BMC Genomics, vol. 8, pp. 243–250, 2007. View at Publisher · View at Google Scholar · View at PubMed
30. J. L. Aerts, M. I. Gonzales, and S. L. Topalian, “Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR,” BioTechniques, vol. 36, no. 1, pp. 84–91, 2004.